Dosage & Administration Drug label Prior authorization Pharmacy Financial assistance

Cablivi

(caplacizumab)

Cablivi 11 MG Injection

NO BLACK BOX WARNING

Dosage & administration

* CABLIVI should be administered upon the initiation of plasma exchange therapy. The recommended dose of CABLIVI is as follows:
* First day of treatment: 11 mg bolus intravenous injection at least 15 minutes prior to plasma exchange followed by an 11 mg subcutaneous injection after completion of plasma exchange on day 1.
* Subsequent treatment during daily plasma exchange: 11 mg subcutaneous injection once daily following plasma exchange.
* Treatment after the plasma exchange period: 11 mg subcutaneous injection once daily for 30 days beyond the last plasma exchange.
* If after initial treatment course, sign(s) of persistent underlying disease such as suppressed ADAMTS13 activity levels remain present, treatment may be extended for a maximum of 28 days.
* Discontinue CABLIVI if the patient experiences more than 2 recurrences of aTTP, while on CABLIVI.

* The first dose should be administered by a healthcare provider as a bolus intravenous injection. Administer subsequent doses subcutaneously in the abdomen.

drug label

Cablivi prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Cablivi prior authorization resources

Most recent Cablivi prior authorization forms

View By Payer

Updated: May 30, 2023Cigna - Cablivi Prior Authorization Form

Learn More

Benefits investigation

PDFCablivi Patient Solutions Enrollment Form

Learn More

pharmacy

Cablivi preferred pharmacy

OTHERPharmacy List

financial assistance

Cablivi financial assistance options

Co-pay savings program

commercial only

PDFCablivi Patient Solutions Enrollment Form

OTHEREnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

PDFCablivi Patient Solutions Enrollment Form

OTHERPatient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Cablivi patient education

Getting started on Cablivi

BRAND PAGEInstructions For Use: aTTP/iTTP

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

BRAND PAGEAbout Cablivi

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGESide Effects

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHERView How to Take Cablivi

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

VIDEOPatient Stories

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHERPatient Resources

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDFDoctor Discussion Guide

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDFPatient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHERCreate a Personalized aTTP/iTTP Card

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Other resources

Learn More

Cablivi FAQs

How is the dosage of Cablivi?Cablivi is available in 1 dosages, including 11 mg Injection

What does Cablivi treat?Cablivi treats Thrombotic Thrombocytopenic Purpura

How Is Cablivi Administered?Cablivi is administered as a Injectable

FAQ Data Source

Cablivi

Dosage & administration

drug label

Cablivi prescribing information

prior authorization

Cablivi prior authorization resources

Most recent Cablivi prior authorization forms

Benefits investigation

pharmacy

Cablivi preferred pharmacy

financial assistance

Cablivi financial assistance options

Co-pay savings program

Foundation programs

patient education

Cablivi patient education

Getting started on Cablivi

Patient toolkit

Other resources

people also ask

Cablivi FAQs